This startup wants to prove gene-editing embryos is safe for making healthy babies

calle 20260914 00352



Cathy Tie, the founder and CEO of Origin Genomics, replenishes nutrients sustaining cells the New York City startup is using to test its technology for repairing defective genes.

Origin Genomics aims to prove that the potential benefits of its technology for editing disease-causing genes in human embryos outweigh the risks.

(Image credit: Mackenzie Calle for NPR)

npr rss



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *